Company intelligence / Profile preview
ORENDA
Manhattan, New York, United Statesorenda-pharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Orenda Biotech is a newly formed private biotechnology company registered in New York in February 2024. Publicly available information indicates it is an active corporate entity, but there is little disclosed detail on its scientific focus, pipeline, products, management, or operating activities. Based on the company name and registration, it appears to be intended as a life sciences or biotechnology business, but its therapeutic areas, modalities, and development stage cannot be confirmed from accessible sources. As a result, Orenda Biotech should currently be treated as an early-stage, minimally disclosed private company rather than an established operating drug developer.
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on ORENDA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ORENDA.